Article
Safety and Efficacy of Rituximab in Systemic Sclerosis: A Systematic Review and Meta-analysis
2019-12-16
Abstract excerpt
<title>Abstract</title> <p>Background: Rituximab has been widely proposed to treat systemic sclerosis (SSc) by depletion of pathogenic B cells. Nonetheless, the clinical benefit of Rituximab in SSc remains contentious. <h4>Objective:</h4> This meta-analysis was conducted to systematically evaluate the safety and efficacy profile of Rituximab in SSc patients. <h4>Methods:</h4> We performed a systematic online quer...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 981ccf57-d3e0-53da-9004-7d51079267bf
- DOI
- 10.21203/rs.2.18603/v1
